Carbon Dioxide for the Treatment of Febrile Seizures

Phase 1

• Conditions: febrile seizures; Therapeutic area: Body processes [G] - Physiological processes [G07]

• Registration Number: EUCTR2011-001403-12-DE
• Lead Sponsor: Charite Universitaetsmedizin Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-28
• Last Update Posted: 8 November 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 288

Inclusion Criteria

- Condition after febrile seizure
- Age 12 (resp. 6) months to 5 years
- Written informed consent
Are the trial subjects under 18? yes
Number of subjects for this age range: 288
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- severe other organic disease
- meningitis as possible cause for the cerebral seizure
- neurologic disease or cerebral dysplasia
- cerebrale seizures without fever in the medical history
- hypersynchronic eeg activity
- disorder of the respiratory tract (Asthma e.g.)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified